drugset / Trial / NCT00321373

Study to Evaluate an Influenza Vaccine Candidate

NCT00321373

Phase 2 Completed 1220 enrolled GlaxoSmithKline
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to evaluate the immune response and safety of influenza vaccine candidate with or without adjuvant compared to Fluarix™ administered intramuscularly in elderly aged 60 years old and above.

Timeline

Start
2006-05-11
Primary completion
2006-07-01
Completion
2006-07-18

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1247446A Vaccine Intramuscular
Comparator Influenza Virus Vaccine Vaccine Intramuscular

Indications